Insider trades

Henderson Michael Thomas, Director of Spyre Therapeutics SYRE, has filed 0 purchases and 54 sales on the open market. Over the past 12 months that comes to a net sale of $33.7M. The latest trade was on 06/22.

Henderson Michael Thomas

Director
First filing
23/12/20
Trades
67 trades
Buys / sales
0 / 54
12-month net buying
−$33.7M
Last trade
06/22

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2206/2480,000 sh$132.54$10,603,200−7.3%
Open-market sale10b5-1 plan06/2206/2320,000 sh$100.00$2,000,000−22.6%
Open-market sale10b5-1 plan06/1006/1220,000 sh6 trades$83.38avg.$1,667,621.66−1.8%
Open-market sale10b5-1 plan05/1305/1520,000 sh2 trades$82.09avg.$1,641,710.73−1.8%
SYRE
Open-market sale10b5-1 plan05/0805/0880,000 sh4 trades$74.40avg.$5,952,050.43−47.4%
Open-market sale10b5-1 plan04/0804/1020,000 sh3 trades$82.58avg.$1,651,664−1.7%
Open-market sale10b5-1 plan03/1103/1320,000 sh3 trades$74.78avg.$1,495,604.52−1.7%
Open-market sale10b5-1 plan02/1102/1320,000 sh3 trades$63.35avg.$1,266,952.92−1.7%
Open-market sale10b5-1 plan01/1401/1620,000 sh6 trades$81.11avg.$1,622,159.12−1.6%
Open-market sale10b5-1 plan25/12/1025/12/1220,000 sh3 trades$75.38avg.$1,507,656.55−1.6%
Open-market sale10b5-1 plan25/12/0425/12/0540,000 sh$75.01$3,000,400−3.1%
Open-market sale10b5-1 plan25/11/1325/11/1320,000 sh4 trades$63.01avg.$1,260,236.1−1.5%
Open-market sale10b5-1 plan25/03/0525/03/0710,000 sh2 trades$30.15avg.$301,511.36−0.8%
Open-market sale10b5-1 plan25/02/0525/02/0715,000 sh$40.58$608,700−1.1%
Open-market sale10b5-1 plan25/01/0825/01/1015,000 sh2 trades$48.85avg.$732,692.88−1.1%
Open-market sale10b5-1 plan24/12/0424/12/0615,000 sh2 trades$46.58avg.$698,653.68−1.1%
Open-market sale10b5-1 plan24/11/0624/11/0815,000 sh2 trades$59.22avg.$888,320−1.1%
Open-market sale10b5-1 plan24/10/0224/10/0440,000 sh2 trades$56.23avg.$2,249,307.04−2.9%
Open-market sale10b5-1 plan24/09/0424/09/0640,000 sh2 trades$47.62avg.$1,904,841.05−2.8%
Open-market sale10b5-1 plan24/08/0724/08/0940,000 sh3 trades$40.62avg.$1,624,764.04−2.7%